When Apalutamide was employed as an intervention, itsignificantly enhanced inducible nitric oxide synthase (iNOS) and reducedendothelial nitric oxide synthase (eNOS) levels, resulting in a further declinein nitric oxide (NO) levels, which has emerged as an important mechanism fordeveloping hypertension [15]. The gene discussed is NOS2; the disease is hypertensive disorder.